Image 1 of 2
Image 2 of 2
Packaging & supply options
Your format, your way.
The same research peptide, with a choice of accessories and supply formats. Here’s what each option includes.
BAC water
Vial kit
Lyophilised peptide vial with separately packaged, complimentary BAC water.
BAC water + syringes
Syringe kit
Lyophilised peptide vial, BAC water and syringes.
BAC water + pen
Injection pen kit
Lyophilised peptide vial, BAC water and an injection pen.
Pen + pen needles
Reconstituted pen
VIETNAM ONLYPeptide solution supplied in a pen at the stated concentration, with pen needles.
For laboratory research only. Not for human or veterinary use.
Everform Pharma · Compound profile
Adamax.
A closer look at the evidence.
Explore the proposed Semax connection, the importance of molecular identity and the questions that remain unanswered.
What is Adamax?
Adamax is a research-market product name commonly used for a proposed modified Semax analogue. Online descriptions associate it with exploratory neuropeptide research, but a commercial name alone does not establish an exact molecular structure.
For this profile, searches for Adamax together with peptide, Semax and adamantane did not identify a peer-reviewed study directly testing the named compound. This is a finding from the literature search conducted on 13 November 2026, not proof that no unpublished or unindexed work exists.
Accordingly, this article does not assign Adamax a confirmed mechanism, half-life, potency ranking or clinical benefit. The related studies below concern Semax or acetylated Semax and are clearly identified as background.
How it works
A compound-specific mechanism for Adamax could not be established from the primary literature located. Claims about BDNF, brain penetration or prolonged activity therefore remain unverified for this product.
Semax provides a related research context. In rats, Dolotov and colleagues examined binding to basal-forebrain membranes and reported increased brain-derived neurotrophic factor (BDNF) protein in that region. A separate study investigated BDNF and TrkB-related changes in rat hippocampus. Neither experiment tested Adamax. [1] [2]
Structural modification is not automatically an improvement. Work comparing Semax with N-acetyl Semax found changes in metal coordination and a different outcome in a copper-toxicity cell assay. That study illustrates why derivatives need their own evidence; it does not establish Adamax’s effects. [3]
NEUROPEPTIDE CONTEXT
Understanding the Semax studies often cited alongside Adamax.
IDENTITY FIRST
Separating an intended molecular design from a verified structure and measured biological activity.
Main research areas
The table distinguishes topics of interest from findings actually demonstrated for Adamax.
| Research topic | Evidence and limits |
|---|---|
| Neurotrophic signalling | Rat studies measured BDNF-related responses to Semax. They provide background, not Adamax evidence. [1] [2] |
| Peptide modification | Semax and N-acetyl Semax differed in a laboratory metal-binding and cell-toxicity study. Adamax was not tested. [3] |
| Persistence and brain exposure | No Adamax-specific pharmacokinetic or brain-distribution measurement was identified in the literature search for this article. |
| Memory, focus and cognition | No peer-reviewed Adamax clinical trial establishing these outcomes was identified. Related-compound findings cannot supply that missing evidence. |
A study of a related peptide is not a study of Adamax. Human-derived cell lines are not human clinical trials.
What published findings show
Semax in rat basal forebrain: Dolotov and colleagues reported specific, reversible binding in membrane preparations and increased BDNF protein in rats. The experiment concerned Semax and a defined brain region; it did not establish cognitive benefits from Adamax in people. [1]
Semax in rat hippocampus: A separate study reported changes in BDNF and TrkB expression and signalling after Semax exposure. Such molecular measurements support investigation of neural plasticity, but are not equivalent to a measured improvement in human memory or attention. [2]
N-acetyl Semax in laboratory assays: Magrì and colleagues found that acetylation changed copper coordination. In their neuroblastoma-cell experiment, the acetylated peptide did not retain the parent’s protection against copper-induced toxicity. This result is specific to that assay and modification; it is not a general safety assessment of Adamax. [3]
Adamax itself: The search for this article did not locate primary evidence confirming its proposed biological advantages over Semax. Numerical claims about duration, potency or BDNF increases are therefore not presented as established product properties.
Adamax remains an evidence-limited research product. The related primary studies cited here do not establish its effectiveness, safety, brain penetration or superiority to Semax.
The Everform product, at a glance
Product labelAdamax
Labelled vial amount10 mg
Vial formatLyophilised peptide powder
Supply optionsCheck the current product selector
Everform Pharma is based in Da Nang, Vietnam. The labelled vial amount describes product content, not a recommended dose. Complimentary BAC water is included with every order.
Explore Your format, your way →
For a modified peptide, request documentation specifying the intended sequence, terminal modifications and analytical identity. This profile does not assume a molecular formula, attachment site or molecular weight from the product name alone.
The full REF on the product should match the relevant documentation. The security sticker repeats the product identifier and should match the vial or supplied container, including a pen where applicable; it is not a separate new ID. Follow the actual label for storage and expiry.
Identity, chromatographic purity and measured content are different results. A purity percentage alone does not verify molecular structure, biological activity or the amount of peptide in the vial.
Common questions
Is Adamax the same as Semax?
No. Adamax is marketed as a modified analogue. Results from Semax cannot be assumed to describe a differently modified molecule.
Has Adamax been shown to increase BDNF?
No compound-specific primary study establishing that effect was identified for this article. The cited BDNF experiments used Semax in rats. [1] [2]
Is it proven to last longer or work better than Semax?
No comparative primary study establishing those claims was located. Persistence and potency need direct measurements on a chemically defined test material.
Do terminal modifications always improve a peptide?
No. A modification can change chemistry and biological behaviour. The Semax acetylation study provides an example, without determining what any other derivative will do. [3]
Does 10 mg describe a recommended dose?
No. It is the labelled amount in the vial, not a dose, spray concentration or administration instruction.
Does a nasal-spray photograph establish a studied formulation?
No. Packaging does not establish absorption, stability, sterility or clinical performance. Those questions require formulation-specific evidence and documentation.
References
These are original studies of related compounds, included for context. None directly tests Adamax.
Everform Pharma · Da Nang, Vietnam
Educational product information.
For laboratory research only.
Not for human or veterinary use.
